Digital Turbine
APPS
Tempus AI
TEM
Doximity
DOCS
4
Veeva Systems
VEEV
5
Palantir
PLTR
US Stock MarketDetailed Quotes
SRNE Sorrento Therapeutics
- 0.001
- 0.0000.00%
15min DelayClose Mar 18 16:00 ET
385.90KMarket Cap0.00P/E (TTM)
0.005High0.001Low81.17KVolume0.001Open0.001Pre Close59.80Turnover0.02%Turnover Ratio0.00P/E (Static)551.28MShares0.08552wk High0.00P/B382.07KFloat Cap0.00052wk Low--Dividend TTM545.82MShs Float302.685Historical High--Div YieldTTM600.00%Amplitude0.000Historical Low0.000Avg Price1Lot Size
Sorrento Therapeutics Key Stats
EPS
According to the latest financial report of Sorrento Therapeutics, the latest earnings per share (TTM) for the company is -0.17. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Sorrento Therapeutics's free cash flow? The latest report shows it as -55.80M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Sorrento Therapeutics shows that the company's current ratio is 0.50, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Sorrento Therapeutics, the quick ratio is 0.43, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Sorrento Therapeutics? The latest ROE figure is -395.07%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Sorrento Therapeutics, the total asset return on investment (ROA) is -20.77%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Sorrento Therapeutics's latest financial report to see how their gross margin is doing - currently at 43.74%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Sorrento Therapeutics, the net profit margin is -722.37%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending Stocks
AI application software AI application software
AI application software stocks refer to companies that utilize advanced algorithms and computing capabilities in the field of artificial intelligence to develop and provide innovative software solutions. Through the application of artificial intelligence technology, these companies have improved the efficiency and functionality of their products to meet the needs of different industries, such as automation, data analysis, customer service, etc. AI application software stocks refer to companies that utilize advanced algorithms and computing capabilities in the field of artificial intelligence to develop and provide innovative software solutions. Through the application of artificial intelligence technology, these companies have improved the efficiency and functionality of their products to meet the needs of different industries, such as automation, data analysis, customer service, etc.
Unlock Now
Investment Course
Choose stocks based on financial reports
Quickly master financial season learning guidelines
When the financial season comes, company stock prices are the most likely to rise and fall, and many excellent investors will see the financial season as a good
[2025.2] How should NVIDIA's performance be viewed? The key indicator to watch for short-term stock prices is this.
NVIDIA has been one of the best-performing Technology giants in the US stock market over the past two years, and since 2024, its stock price has experienced sig
How to view Tesla's performance in January 2025? Pay attention to these four key points.
It's earnings season for US stocks again. The performance of giant companies not only affects their own stock prices but also influences the overall trend of th